{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T22:39:23Z","timestamp":1773268763648,"version":"3.50.1"},"reference-count":103,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T00:00:00Z","timestamp":1592352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","award":["70112872\/70113144"],"award-info":[{"award-number":["70112872\/70113144"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Methadone, which is used as maintenance medication for outpatient treatment of opioid dependence or as an analgesic drug, has been suggested by preclinical in vitro and mouse studies to induce cell death and sensitivity to chemo- or radiotherapy in leukemia, glioblastoma, and carcinoma cells. These data together with episodical public reports on long-term surviving cancer patients who use methadone led to a hype of methadone as an anti-cancer drug in social and public media. However, clinical evidence for a tumoricidal effect of methadone is missing and prospective clinical trials, except in colorectal cancer, are not envisaged because of the limited preclinical data available. The present article reviews the pharmacokinetics, potential molecular targets, as well as the evidence for a tumoricidal effect of methadone in view of the therapeutically achievable doses in the brain. Moreover, it provides original in vitro data showing that methadone at clinically relevant concentrations fails to impair clonogenicity or radioresistance of glioblastoma cells.<\/jats:p>","DOI":"10.3390\/biom10060917","type":"journal-article","created":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T13:11:32Z","timestamp":1592399492000},"page":"917","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Against Repurposing Methadone for Glioblastoma Therapy"],"prefix":"10.3390","volume":"10","author":[{"given":"Tatjana","family":"Vatter","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, University of T\u00fcbingen, 72076 T\u00fcbingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lukas","family":"Klumpp","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of T\u00fcbingen, 72076 T\u00fcbingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrin","family":"Ganser","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of T\u00fcbingen, 72076 T\u00fcbingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolai","family":"Stransky","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of T\u00fcbingen, 72076 T\u00fcbingen, Germany"},{"name":"Department of Pharmacology, Toxicology and Clinical Pharmacy, Institute of Pharmacy, University of T\u00fcbingen, 72076 T\u00fcbingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Zips","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of T\u00fcbingen, 72076 T\u00fcbingen, Germany"},{"name":"German Cancer Consortium (DKTK), Partner Site T\u00fcbingen, T\u00fcbingen, Germany, and German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4742-3962","authenticated-orcid":false,"given":"Franziska","family":"Eckert","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of T\u00fcbingen, 72076 T\u00fcbingen, Germany"},{"name":"German Cancer Consortium (DKTK), Partner Site T\u00fcbingen, T\u00fcbingen, Germany, and German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan M.","family":"Huber","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of T\u00fcbingen, 72076 T\u00fcbingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,6,17]]},"reference":[{"key":"ref_1","first-page":"193","article-title":"On pethidine and methadone derivatives","volume":"2","author":"Wolff","year":"1949","journal-title":"Bull. World Health Organ."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/jlac.19495610107","article-title":"\u00dcber eine neue Klasse von spasmolytisch und analgetisch wirkenden Verbindungen, I","volume":"561","author":"Ehrhart","year":"1949","journal-title":"Justus Liebigs Ann. Chem."},{"key":"ref_3","first-page":"63","article-title":"The action of 1, 1-diphenyl-1-(dimethylaminoisopropyl)-butanone-2, a potent analgesic agent","volume":"87","author":"Scott","year":"1946","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0740-5472(02)00259-3","article-title":"History and current status of opioid maintenance treatments: Blending conference session","volume":"23","author":"Kreek","year":"2002","journal-title":"J. Subst. Abuse Treat."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1001\/jama.1965.03090080008002","article-title":"A medical treatment for diacetylmorphine (heroin) addiction. A clinical trial with methadone hydrochloride","volume":"193","author":"Dole","year":"1965","journal-title":"JAMA"},{"key":"ref_6","first-page":"1048","article-title":"d-Methadone blocks morphine tolerance and N-methyl-d-aspartate-induced hyperalgesia","volume":"289","author":"Davis","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_7","first-page":"435","article-title":"Pharmacology of methadone and its isomers","volume":"71","author":"Inturrisi","year":"2005","journal-title":"Minerva Anestesiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1001\/jama.2013.280319","article-title":"Glioblastoma and other malignant gliomas: A clinical review","volume":"310","author":"Omuro","year":"2013","journal-title":"JAMA"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1001\/jama.2017.18718","article-title":"Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial","volume":"318","author":"Stupp","year":"2017","journal-title":"JAMA"},{"key":"ref_11","unstructured":"American-Cancer-Society (2020, May 05). Survival Rates for Selected Adult Brain and Spinal Cord Tumors. Available online: https:\/\/www.cancer.org\/cancer\/brain-spinal-cord-tumors-adults\/detection-diagnosis-staging\/survival-rates.html."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1159\/000485753","article-title":"Cellular Effects of the Antiepileptic Drug Valproic Acid in Glioblastoma","volume":"44","author":"Eckert","year":"2017","journal-title":"Cell Physiol. Biochem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1073\/pnas.87.9.3294","article-title":"Opioid and nicotine receptors affect growth regulation of human lung cancer cell lines","volume":"87","author":"Maneckjee","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1073\/pnas.89.4.1169","article-title":"Nonconventional opioid binding sites mediate growth inhibitory effects of methadone on human lung cancer cells","volume":"89","author":"Maneckjee","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_15","first-page":"1033","article-title":"Opioids induce while nicotine suppresses apoptosis in human lung cancer cells","volume":"5","author":"Maneckjee","year":"1994","journal-title":"Cell Growth Differ."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.4161\/cc.28493","article-title":"Opioid receptor activation triggering downregulation of cAMP improves effectiveness of anti-cancer drugs in treatment of glioblastoma","volume":"13","author":"Friesen","year":"2014","journal-title":"Cell Cycle"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"6059","DOI":"10.1158\/0008-5472.CAN-08-1227","article-title":"Methadone, commonly used as maintenance medication for outpatient treatment of opioid dependence, kills leukemia cells and overcomes chemoresistance","volume":"68","author":"Friesen","year":"2008","journal-title":"Cancer Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"677","DOI":"10.18632\/oncotarget.952","article-title":"Cell death sensitization of leukemia cells by opioid receptor activation","volume":"4","author":"Friesen","year":"2013","journal-title":"Oncotarget"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.21873\/anticanres.11438","article-title":"Safety and tolerance of d, l-methadone in combination with chemotherapy in patients with glioma","volume":"37","author":"Onken","year":"2017","journal-title":"Anticancer Res."},{"key":"ref_20","unstructured":"Deutsche-Gesellschaft-f\u00fcr-H\u00e4matologie-und-Medizinische-Onkologie (2020, May 11). DGHO Stellungnahme Methadon. Available online: https:\/\/www.dgho.de\/publikationen\/stellungnahmen\/gute-aerztliche-praxis\/methadon\/DGHO_Stellungnahme_Methadon 20170426_.pdf\/view."},{"key":"ref_21","unstructured":"Deutsche-Krebshilfe (2020, May 11). Stellungnahme der Deutschen Krebshilfe zum Thema \u2018Methadon in der Krebstherapie\u2019. Available online: https:\/\/www.krebshilfe.de\/fileadmin\/Downloads\/PDFs\/Stellungnahmen\/Deutsche_Krebshilfe_Stellungnahme_Methadon_10_2019.pdf."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.phrs.2004.05.002","article-title":"Methadone\u2014metabolism, pharmacokinetics and interactions","volume":"50","author":"Ferrari","year":"2004","journal-title":"Pharmacol. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2165\/00003088-200241140-00003","article-title":"Interindividual variability of the clinical pharmacokinetics of methadone: Implications for the treatment of opioid dependence","volume":"41","author":"Eap","year":"2002","journal-title":"Clin. Pharmacokinet."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/BF00542102","article-title":"Single dose pharmacokinetics and bioavailability of methadone in man studied with a stable isotope method","volume":"20","author":"Meresaar","year":"1981","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/00007691-199606000-00001","article-title":"Stereoselective pharmacokinetics of methadone in chronic pain patients","volume":"18","author":"Kristensen","year":"1996","journal-title":"Ther. Drug Monit."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0304-3959(88)90290-4","article-title":"Estimation of methadone clearance: Application in the management of cancer pain","volume":"33","author":"Plummer","year":"1988","journal-title":"Pain"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/clpt.1990.37","article-title":"Binding of d-methadone, l-methadone, and dl-methadone to proteins in plasma of healthy volunteers: Role of the variants of alpha 1-acid glycoprotein","volume":"47","author":"Eap","year":"1990","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.2042-7158.1996.tb05917.x","article-title":"Influence of plasma-protein binding on analgesic effect of methadone in rats with spontaneous withdrawal","volume":"48","author":"Garrido","year":"1996","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/clpt.1982.217","article-title":"Methadone plasma protein binding: Alterations in cancer and displacement from alpha 1-acid glycoprotein","volume":"32","author":"Abramson","year":"1982","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1016\/j.xphs.2018.08.025","article-title":"Methadone Metabolism and Drug-Drug Interactions: In Vitro and In Vivo Literature Review","volume":"107","author":"Volpe","year":"2018","journal-title":"J. Pharm. Sci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/cpt1975173258","article-title":"Disposition of methadone in methadone maintenance","volume":"17","author":"Anggard","year":"1975","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1080\/14656566.2017.1409722","article-title":"Recommendations for buprenorphine and methadone therapy in opioid use disorder: A European consensus","volume":"18","author":"Dematteis","year":"2017","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1001\/jama.1988.03410200081030","article-title":"Implications of methadone maintenance for theories of narcotic addiction","volume":"260","author":"Dole","year":"1988","journal-title":"JAMA"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Mohamad, N., Salehuddin, R.M., Ghazali, B., Bakar, N.H.A., Musa, N., Ibrahim, M.A., Adnan, L.H.M., Rashidi, A., and Ismail, R. (2013). Plasma methadone level monitoring in methadone maintenance therapy: A personalised methadone therapy. New Insights Toxic. Drug Test.","DOI":"10.5772\/54850"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/jat\/bkr013","article-title":"Blood methadone concentrations in living and deceased persons: Variations over time, subject demographics, and relevance of coingested drugs","volume":"36","author":"Jones","year":"2012","journal-title":"J. Anal. Toxicol."},{"key":"ref_36","unstructured":"Centers for Disease Control and Prevention (CDC) (2012). Vital signs: Risk for overdose from methadone used for pain relief\u2014United States, 1999\u20132010. MMWR Morb. Mortal. Wkly. Rep., 61, 493\u2013497."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.forsciint.2013.01.038","article-title":"Postmortem blood and tissue concentrations of R-and S-enantiomers of methadone and its metabolite EDDP","volume":"226","author":"Jantos","year":"2013","journal-title":"Forensic Sci. Int."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1093\/ajcp\/61.6.778","article-title":"Evaluation of deaths from drug overdose: A clinicopathologic study","volume":"61","author":"Irey","year":"1974","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/hup.630","article-title":"The effects of methadone and its role in fatalities","volume":"19","author":"Corkery","year":"2004","journal-title":"Hum. Psychopharmacol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s40291-017-0311-y","article-title":"Pharmacogenetics of Methadone Response","volume":"22","author":"Fonseca","year":"2018","journal-title":"Mol. Diag. Ther."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jpainsymman.2004.06.012","article-title":"Measurement of QTc in patients receiving chronic methadone therapy","volume":"29","author":"Cruciani","year":"2005","journal-title":"J. Pain Sympt. Manag."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0304-3959(03)00205-7","article-title":"QTc interval prolongation associated with intravenous methadone","volume":"105","author":"Kornick","year":"2003","journal-title":"Pain"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"501","DOI":"10.7326\/0003-4819-137-6-200209170-00010","article-title":"Torsade de pointes associated with very-high-dose methadone","volume":"137","author":"Krantz","year":"2002","journal-title":"Ann. Intern. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2146\/ajhp070392","article-title":"Methadone-associated Q-T interval prolongation and torsades de pointes","volume":"66","author":"Stringer","year":"2009","journal-title":"Am. J. Health Syst. Pharm."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/neuonc\/nox175","article-title":"Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data","volume":"20","author":"Sarkaria","year":"2018","journal-title":"Neuro. Oncol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0376-8716(92)90058-K","article-title":"The use of plasma levels to optimize methadone maintenance treatment","volume":"30","author":"Loimer","year":"1992","journal-title":"Drug Alcohol Depend."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1046\/j.1360-0443.2003.00425.x","article-title":"The role of methadone in drug-related deaths in the west of Scotland","volume":"98","author":"Seymour","year":"2003","journal-title":"Addiction"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/PAF.0b013e3181ca4b1e","article-title":"Contributing factors to methadone-related deaths in Ontario","volume":"31","author":"Albion","year":"2010","journal-title":"Am. J. Forensic Med. Pathol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1126\/science.178.4064.984","article-title":"Blood-brain barrier: Penetration of morphine, codeine, heroin, and methadone after carotid injection","volume":"178","author":"Oldendorf","year":"1972","journal-title":"Science"},{"key":"ref_50","first-page":"513","article-title":"Development of a \"blood-brain barrier\" to methadone in the newborn rat","volume":"192","author":"Peters","year":"1975","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1124\/mol.106.023796","article-title":"In vivo activation of human pregnane X receptor tightens the blood-brain barrier to methadone through P-glycoprotein up-regulation","volume":"70","author":"Bauer","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s00213-003-1718-1","article-title":"Brain penetration of methadone (R)-and (S)-enantiomers is greatly increased by P-glycoprotein deficiency in the blood\u2013brain barrier of Abcb1a gene knockout mice","volume":"173","author":"Wang","year":"2004","journal-title":"Psychopharmacology"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.bcp.2003.08.027","article-title":"Variable modulation of opioid brain uptake by P-glycoprotein in mice","volume":"67","author":"Dagenais","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.clpt.2006.09.011","article-title":"ABCB1 genetic variability and methadone dosage requirements in opioid-dependent individuals","volume":"80","author":"Coller","year":"2006","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.clpt.2006.09.012","article-title":"ABCB1 and cytochrome P450 genotypes and phenotypes: Influence on methadone plasma levels and response to treatment","volume":"80","author":"Crettol","year":"2006","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/sj.clpt.6100305","article-title":"No Influence of ABCB1 Haplotypes on Methadone Dosage Requirement","volume":"83","author":"Crettol","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10354-018-0623-5","article-title":"Methadone as anticancer treatment: Hype, hope, or hazard?","volume":"168","author":"Kreye","year":"2018","journal-title":"Wien. Med. Wochenschr."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1002\/ijc.31356","article-title":"Methadone against cancer: Lost in translation","volume":"143","author":"Theile","year":"2018","journal-title":"Int. J. Cancer"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"PL45","DOI":"10.1016\/0024-3205(94)00937-6","article-title":"The mu1, mu2, delta, kappa opioid receptor binding profiles of methadone stereoisomers and morphine","volume":"56","author":"Kristensen","year":"1995","journal-title":"Life Sci."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1124\/pr.112.007138","article-title":"Mu opioids and their receptors: Evolution of a concept","volume":"65","author":"Pasternak","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1523\/JNEUROSCI.2442-16.2016","article-title":"Functional mu-Opioid-Galanin Receptor Heteromers in the Ventral Tegmental Area","volume":"37","author":"Moreno","year":"2017","journal-title":"J. Neurosci."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1172\/JCI126912","article-title":"Opioid-galanin receptor heteromers mediate the dopaminergic effects of opioids","volume":"129","author":"Cai","year":"2019","journal-title":"J. Clin. Investig."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1213\/01.ANE.0000099723.75548.DF","article-title":"Functional inhibition by methadone of N-methyl-d-aspartate receptors expressed in Xenopus oocytes: Stereospecific and subunit effects","volume":"98","author":"Callahan","year":"2004","journal-title":"Anesth. Analg."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0304-3940(95)11364-3","article-title":"Ketobemidone, methadone and pethidine are non-competitive N-methyl-d-aspartate (NMDA) antagonists in the rat cortex and spinal cord","volume":"187","author":"Ebert","year":"1995","journal-title":"Neurosci. Lett."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0304-3940(97)13391-2","article-title":"The d- and l-isomers of methadone bind to the non-competitive site on the N-methyl-d-aspartate (NMDA) receptor in rat forebrain and spinal cord","volume":"223","author":"Gorman","year":"1997","journal-title":"Neurosci. Lett."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0006-8993(00)02369-6","article-title":"Morphine and methadone have different effects on calcium channel currents in neuroblastoma cells","volume":"870","author":"Yang","year":"2000","journal-title":"Brain Res."},{"key":"ref_67","first-page":"366","article-title":"Blockade of rat alpha3beta4 nicotinic receptor function by methadone, its metabolites, and structural analogs","volume":"299","author":"Xiao","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1089\/jpm.2009.0427","article-title":"The effect of oral methadone on the QTc interval in advanced cancer patients: A prospective pilot study","volume":"13","author":"Heppe","year":"2010","journal-title":"J. Palliat. Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/sj.clpt.6100120","article-title":"Stereoselective block of hERG channel by (S)-methadone and QT interval prolongation in CYP2B6 slow metabolizers","volume":"81","author":"Eap","year":"2007","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0014-2999(99)00736-0","article-title":"The dual modulation of GIRK1\/GIRK2 channels by opioid receptor ligands","volume":"385","author":"Ulens","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/bja\/aeu206","article-title":"Methadone is a local anaesthetic-like inhibitor of neuronal Na+ channels and blocks excitability of mouse peripheral nerves","volume":"114","author":"Stoetzer","year":"2014","journal-title":"Br. J. Anaesth."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s12013-012-9406-6","article-title":"Methadone but not morphine inhibits lubiprostone-stimulated Cl\u2212 currents in T84 intestinal cells and recombinant human ClC-2, but not CFTR Cl\u2212 currents","volume":"66","author":"Cuppoletti","year":"2013","journal-title":"Cell Biochem. Biophys."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1017\/S1461145709990848","article-title":"Interaction of drugs of abuse and maintenance treatments with human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2)","volume":"13","author":"Tournier","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.bcp.2009.07.002","article-title":"Opiates inhibit paclitaxel uptake by P-glycoprotein in preparations of human placental inside-out vesicles","volume":"78","author":"Hemauer","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nbt1284","article-title":"Relating protein pharmacology by ligand chemistry","volume":"25","author":"Keiser","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0092-8674(95)90340-2","article-title":"A mechanistic link between an inherited and an acquird cardiac arrthytmia: HERG encodes the IKr potassium channel","volume":"81","author":"Sanguinetti","year":"1995","journal-title":"Cell"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tox.2010.10.010","article-title":"Inhibitory action of methadone and its metabolites on erg-mediated K+ current in GH(3) pituitary tumor cells","volume":"280","author":"Huang","year":"2011","journal-title":"Toxicology"},{"key":"ref_78","first-page":"1797","article-title":"Methadone hydrochloride and leukemia cells: Effects on cell viability, DNA fragmentation and apoptotic proteins expression level","volume":"32","author":"Kua","year":"2019","journal-title":"Pak. J. Pharm. Sci."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.leukres.2011.06.035","article-title":"Induction of apoptosis in pediatric acute lymphoblastic leukemia (ALL) cells by the therapeutic opioid methadone and effective synergy with Bcl-2 inhibition","volume":"35","author":"Singh","year":"2011","journal-title":"Leuk. Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"5910","DOI":"10.1038\/onc.2017.211","article-title":"Genome-wide loss-of-function genetic screening identifies opioid receptor mu1 as a key regulator of L-asparaginase resistance in pediatric acute lymphoblastic leukemia","volume":"36","author":"Kang","year":"2017","journal-title":"Oncogene"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Brawanski, K., Brockhoff, G., Hau, P., Vollmann-Zwerenz, A., Freyschlag, C., Lohmeier, A., Riemenschneider, M.J., Thom\u00e9, C., Brawanski, A., and Proescholdt, M.A. (2018). Efficacy of D, L-methadone in the treatment of glioblastoma in vitro. CNS Oncol.","DOI":"10.2217\/cns-2018-0006"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Shi, L., Pohla, H., Buchner, A., Zhang, L., Pongratz, T., R\u00fchm, A., Zimmermann, W., Gederaas, O.A., Wang, X., and Stepp, H. (2020). MOP-dependent enhancement of methadone on the effectiveness of ALA-PDT for A172 cells by upregulating phosphorylated JNK and BCL2. Photodiagnosis Photodyn. Ther.","DOI":"10.1016\/j.pdpdt.2020.101657"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.bbadis.2010.07.024","article-title":"Methadone induces necrotic-like cell death in SH-SY5Y cells by an impairment of mitochondrial ATP synthesis","volume":"1802","author":"Puerta","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.21873\/anticanres.13511","article-title":"DL-Methadone as an Enhancer of Chemotherapeutic Drugs in Head and Neck Cancer Cell Lines","volume":"39","author":"Landgraf","year":"2019","journal-title":"Anticancer Res."},{"key":"ref_85","first-page":"1369","article-title":"Impact of Methadone on Cisplatin Treatment of Bladder Cancer Cells","volume":"38","author":"Michalska","year":"2018","journal-title":"Anticancer Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0143-4179(03)00007-6","article-title":"Opioids and the apoptotic pathway in human cancer cells","volume":"37","author":"Zagon","year":"2003","journal-title":"Neuropeptides"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"e201800468","DOI":"10.1002\/jbio.201800468","article-title":"Methadone enhances the effectiveness of 5-aminolevulinic acid-based photodynamic therapy for squamous cell carcinoma and glioblastoma in vitro","volume":"12","author":"Shi","year":"2019","journal-title":"J. Biophoton."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s11060-019-03103-4","article-title":"5-aminolevulinic acid photodynamic therapy for the treatment of high-grade gliomas","volume":"141","author":"Mahmoudi","year":"2019","journal-title":"J. Neurooncol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.jocn.2011.02.026","article-title":"Phase 2 trial of temozolomide and pegylated liposomal doxorubicin in the treatment of patients with glioblastoma multiforme following concurrent radiotherapy and chemotherapy","volume":"18","author":"Ananda","year":"2011","journal-title":"J. Clin. Neurosci."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1002\/cncr.20073","article-title":"Pegylated liposomal doxorubicin-efficacy in patients with recurrent high-grade glioma","volume":"100","author":"Hau","year":"2004","journal-title":"Cancer"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Oppermann, H., Matusova, M., Glasow, A., Dietterle, J., Baran-Schmidt, R., Neumann, K., Meixensberger, J., and Gaunitz, F. (2019). D,L-Methadone does not improve radio- and chemotherapy in glioblastoma in vitro. Cancer ChemoTher. Pharmacol.","DOI":"10.1007\/s00280-019-03816-3"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.drugalcdep.2011.05.028","article-title":"Methadone maintenance and cancer risk: An Israeli case registry study","volume":"119","author":"Grinshpoon","year":"2011","journal-title":"Drug Alcohol Depend."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/j.pain.2011.03.023","article-title":"Comparative mortality among Department of Veterans Affairs patients prescribed methadone or long-acting morphine for chronic pain","volume":"152","author":"Krebs","year":"2011","journal-title":"Pain"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1089\/jpm.2016.0316","article-title":"Overall Survival among Cancer Patients Undergoing Opioid Rotation to Methadone Compared to Other Opioids","volume":"20","author":"Reddy","year":"2017","journal-title":"J. Palliat. Med."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3389\/fphar.2020.00489","article-title":"hERG K+ channels promote survival of irradiated leukemia cells","volume":"11","author":"Palme","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.regpep.2010.09.004","article-title":"UMB-3, a novel rabbit monoclonal antibody, for assessing mu-opioid receptor expression in mouse, rat and human formalin-fixed and paraffin-embedded tissues","volume":"167","author":"Lupp","year":"2011","journal-title":"Regul. Pept."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Neuhaus, E., Zirjacks, L., Ganser, K., Klumpp, L., Schuler, U., Zips, D., Eckert, F., and Huber, S.M. (2019). Alternating Electric Fields (TTFields) Activate Cav1.2 Channels in Human Glioblastoma Cells. Cancers, 11.","DOI":"10.3390\/cancers11010110"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s00249-016-1136-z","article-title":"K(+) channel signaling in irradiated tumor cells","volume":"45","author":"Stegen","year":"2016","journal-title":"Eur. Biophys. J."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1159\/000322327","article-title":"Non-selective cation channel-mediated Ca2+-entry and activation of Ca2+\/calmodulin-dependent kinase II contribute to G2\/M cell cycle arrest and survival of irradiated leukemia cells","volume":"26","author":"Heise","year":"2010","journal-title":"Cell Physiol. Biochem."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1007\/s00424-013-1249-5","article-title":"Kv3.4 potassium channel-mediated electrosignaling controls cell cycle and survival of irradiated leukemia cells","volume":"465","author":"Palme","year":"2013","journal-title":"Pflug. Arch."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1158\/1541-7786.MCR-15-0075","article-title":"Ca2+-Activated IK K+ Channel Blockade Radiosensitizes Glioblastoma Cells","volume":"13","author":"Stegen","year":"2015","journal-title":"Mol. Cancer Res."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Klumpp, D., Misovic, M., Szteyn, K., Shumilina, E., Rudner, J., and Huber, S.M. (2016). Targeting TRPM2 Channels Impairs Radiation-Induced Cell Cycle Arrest and Fosters Cell Death of T Cell Leukemia Cells in a Bcl-2-Dependent Manner. Oxid. Med. Cell Longev., 2016.","DOI":"10.1155\/2016\/8026702"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"95896","DOI":"10.18632\/oncotarget.21436","article-title":"TRPM8 is required for survival and radioresistance of glioblastoma cells","volume":"8","author":"Klumpp","year":"2017","journal-title":"Oncotarget"}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/10\/6\/917\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:39:51Z","timestamp":1760175591000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/10\/6\/917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,17]]},"references-count":103,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,6]]}},"alternative-id":["biom10060917"],"URL":"https:\/\/doi.org\/10.3390\/biom10060917","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,17]]}}}